We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Metabolite Drug Tackles Multiple Sclerosis by Altering T Cells' Epigenetic Landscape

News   Mar 01, 2019 | Original Press Release from the Advanced Science Research Center at the Graduate Center of the City University of New York

 
Metabolite Drug Tackles Multiple Sclerosis by Altering T Cells' Epigenetic Landscape

Fumaric Acid Ester Metabolites act as a regulator of the micro RNA MIR-21, which is necessary to create the brain-homing T cells that are active in multiple sclerosis. Credit: Carter Eitreim

 
 
 

RELATED ARTICLES

How Do Psychopaths Control "Dark Impulses"?

News

People with psychopathic traits are predisposed toward antisocial behavior that can result in “unsuccessful” outcomes such as incarceration. Researchers have shown “successful” psychopathic individuals, who control these tendencies, have more developed neural structures that control self-regulation.

READ MORE

A Cure for the Common Cold?

News

Disabling a single, apparently noncritical protein in cells may foil replication of the viruses that cause half of all common colds, polio and other diseases.

READ MORE

A New Study Shows That Vitamin D Deficiency Is Strongly Linked to Increased Mortality, and Encourages Supplementation

News

A new study shows that vitamin D deficiency is strongly linked to increased mortality, and encourages supplementation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE